Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

25 Mar 2009 09:52

RNS Number : 4440P
Seymour Pierce Ltd
25 March 2009
 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader

Seymour Pierce Limited

Company dealt in

Tepnel Life Sciences plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary 1p Shares

Date of dealing

24.03.09

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

Lowest price paid (Note 3)

147,335

0.26760 GBP

0.26760 GBP

Total number of securities sold

Highest price received (Note 3)

Lowest price received (Note 3)

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 3)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Date of disclosure

25.03.09

Contact name

Caroline Woodyer

Telephone number

020 7107 8056

Name of offeree/offeror with which connected

Tepnel Life Sciences

Nature of connection (Note 6)

Nomad & Broker

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMCKPKPCBKKBNB
Date   Source Headline
2nd Feb 20093:10 pmBUSRule 8.3 - TEPNEL LIFE SCIENCES PLC
2nd Feb 20092:55 pmRNSTotal Voting Rights
2nd Feb 20091:55 pmRNSEPT Disclosure
2nd Feb 20091:53 pmRNSEPT Disclosure
2nd Feb 20091:33 pmRNSRule 8.3- Tepnel Life Sciences
2nd Feb 200912:58 pmRNSRule 8.3- (Tepnel Life Sciences Plc)
2nd Feb 200912:21 pmRNSEPT Disclosure
30th Jan 200911:48 amRNSEPT Disclosure
30th Jan 20097:00 amRNSRecommended Cash Offer for Tepnel Life Sciences
29th Jan 20095:10 pmRNSRule 2.10 Announcement
29th Jan 20095:06 pmRNSExercise of Warrants
29th Jan 200912:00 pmRNSEPT Disclosure
28th Jan 20092:45 pmPRNRule 8.3 - Tepnel Life Sciences plc
28th Jan 20099:42 amRNSEPT Disclosure
27th Jan 20099:24 amRNSEPT Disclosure
27th Jan 20098:57 amPRNRule 8.3 - Tepnel Life Sciences
26th Jan 20094:14 pmRNSHolding(s) in Company
26th Jan 20098:22 amRNSEPT Disclosure
23rd Jan 20092:01 pmPRNRule 8.3 - Tepnel Life Sciences plc
23rd Jan 200912:57 pmPRNRule 8.3 - Tepnel Life Sciences
23rd Jan 200912:20 pmRNSEPT Disclosure
23rd Jan 20097:00 amRNSRule 2.10 Announcement
23rd Jan 20097:00 amRNSHolding(s) in Company
22nd Jan 200910:33 amRNSStmnt re Share Price Movement
19th Jan 20094:52 pmRNSHolding(s) in Company
19th Jan 200912:39 pmRNSHolding(s) in Company
8th Jan 20097:00 amRNSTrading Statement
22nd Dec 20084:03 pmRNSNotice of Trading Update
22nd Dec 200811:35 amRNSHolding(s) in Company
17th Dec 20087:05 amRNSHolding(s) in Company
17th Dec 20087:00 amRNSIssue of Equity
26th Nov 20083:13 pmRNSIllinois Selects Tepnel's Cystic Fibrosis Test
21st Nov 20087:00 amRNSHolding(s) in Company
13th Nov 20087:00 amRNSInterim Management Statement
10th Nov 20082:57 pmRNSNotice of Interim Management Statement
28th Oct 20083:20 pmRNSPersons Discharging Managerial Responsibility
24th Oct 20082:35 pmRNSDirector/PDMR Shareholding
20th Oct 200811:32 amRNSHolding(s) in Company
14th Oct 20089:52 amRNSTEPNEL EXPANDS GENETIC SERVICES PORTFOLIO
10th Oct 20089:01 amRNSHolding(s) in Company
2nd Oct 20087:00 amRNSInterim Results
30th Sep 20087:00 amRNSHolding(s) in Company
10th Sep 200812:10 pmRNSGrant of options
4th Sep 20087:00 amRNSAdditional Listing & TVR
2nd Sep 200811:04 amRNSAdditional Listing & TVR
27th Aug 20087:00 amRNSNew DNA Test for Early Detect
14th Aug 20087:00 amRNSNotice of Results
7th Aug 20084:14 pmRNSDirector/PDMR Shareholding
4th Aug 20089:01 amRNSDirector/PDMR Shareholding
31st Jul 20087:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.